A 79-year-old patient is receiving levofloxacin as treatment for a complicated infection. The nurse will monitor for which adverse effect that is associated with this drug?

Choice A reason: Carbapenems, like imipenem, are broad-spectrum antibiotics reserved for severe, multidrug-resistant infections. They are not first-line for uncomplicated urinary tract infections due to their potency and risk of promoting resistance. Sulfonamides are more commonly used for UTIs due to their efficacy and specificity.

Choice B reason: Sulfonamides, like trimethoprim-sulfamethoxazole, are especially useful for urinary tract infections. They inhibit bacterial folate synthesis, targeting pathogens like Escherichia coli, a common UTI cause. Their concentration in urine enhances efficacy, making them a first-line choice for uncomplicated UTIs in susceptible organisms.

Choice C reason: Tetracyclines, like doxycycline, are not typically used for urinary tract infections. They are effective for other infections, like chlamydia, but their spectrum and renal clearance make them less ideal for common UTI pathogens like E. coli compared to sulfonamides or nitrofurantoin.

Choice D reason: Macrolides, like erythromycin, are used for respiratory or soft tissue infections, not primarily for urinary tract infections. They have limited activity against common UTI pathogens like E. coli and do not concentrate effectively in urine, making sulfonamides a more appropriate choice.

Choice A reason: Valerian, used for sleep disorders, has no significant interaction with anticoagulants like warfarin. It may cause sedation but does not affect hepatic CYP450 enzymes or vitamin K-dependent clotting factors, making it safe for patients on anticoagulant therapy, with no impact on bleeding risk or drug metabolism.

Choice B reason: St. John’s wort induces hepatic CYP450 enzymes, particularly CYP3A4, accelerating warfarin metabolism. This reduces warfarin’s anticoagulant effect, decreasing INR and increasing thrombosis risk. Patients must avoid it to maintain therapeutic anticoagulation, making this a critical herbal interaction to report.

Choice C reason: Saw palmetto, used for prostate health, has minimal interaction with anticoagulants. It does not significantly affect CYP450 enzymes or clotting factor synthesis. While it may have mild antiplatelet effects, it is not a primary concern for warfarin therapy compared to St. John’s wort’s enzyme induction.

Choice D reason: Soy has no significant interaction with anticoagulants like warfarin. It does not affect hepatic metabolism or vitamin K-dependent clotting factors. While dietary vitamin K can influence warfarin, soy’s impact is minimal, making it less critical to avoid compared to enzyme inducers like St. John’s wort.